trending Market Intelligence /marketintelligence/en/news-insights/trending/dg9io6wd3imqtrblegxgia2 content esgSubNav
In This List

Eleven Biotherapeutics changes name to Sesen Bio

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Eleven Biotherapeutics changes name to Sesen Bio

Eleven Biotherapeutics Inc. is changing its name to Sesen Bio Inc.

The company's shares will start trading under the new name and Nasdaq ticker symbol SESN, effective May 17.

Eleven Biotherapeutics is a biologic oncology company that focuses on the design and development of targeted protein therapeutics addressing areas of unmet medical needs in cancer.